Difference between revisions of "LncRNAWiki:D"
(Created page with "{|class="wikitable sortable" style="width:90%;text-align:center" |- !Name !Transcript ID !Alias !Description |- |''DACOR1'' |DACOR1 |TCONSN/A00023265 |DNMT1-associated col...") |
|||
(2 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
+ | <div style="padding:0.2em 0.5em;text-align:right;font-size:125%;font-weight:bold;color:#2d2d2d;"> | ||
+ | Jump to section in alphabetical order : [[LncRNAWiki:A|'''A''']] [[LncRNAWiki:B|'''B''']] [[LncRNAWiki:C|'''C''']] '''D''' [[LncRNAWiki:E|'''E''']] [[LncRNAWiki:F|'''F''']] [[LncRNAWiki:G|'''G''']] [[LncRNAWiki:H|'''H''']] [[LncRNAWiki:I|'''I''']] [[LncRNAWiki:J|'''J''']] [[LncRNAWiki:K|'''K''']] [[LncRNAWiki:L|'''L''']] [[LncRNAWiki:M|'''M''']] [[LncRNAWiki:N|'''N''']] [[LncRNAWiki:O|'''O''']] [[LncRNAWiki:P|'''P''']] [[LncRNAWiki:R|'''R''']] [[LncRNAWiki:S|'''S''']] [[LncRNAWiki:T|'''T''']] [[LncRNAWiki:U|'''U''']] [[LncRNAWiki:V|'''V''']] [[LncRNAWiki:W|'''W''']] [[LncRNAWiki:X|'''X''']] [[LncRNAWiki:Y|'''Y''']] [[LncRNAWiki:Z|'''Z''']] [[LncRNAWiki:Featured|'''BACK''']] | ||
+ | </div> | ||
+ | |||
{|class="wikitable sortable" style="width:90%;text-align:center" | {|class="wikitable sortable" style="width:90%;text-align:center" | ||
|- | |- | ||
Line 5: | Line 9: | ||
!Alias | !Alias | ||
!Description | !Description | ||
+ | !Disease | ||
|- | |- | ||
|''DACOR1'' | |''DACOR1'' | ||
Line 10: | Line 15: | ||
|TCONSN/A00023265 | |TCONSN/A00023265 | ||
|DNMT1-associated colon cancer repressed lncRNA 1 | |DNMT1-associated colon cancer repressed lncRNA 1 | ||
+ | |colon cancer | ||
|- | |- | ||
|''DALIR'' | |''DALIR'' | ||
Line 15: | Line 21: | ||
|DALI | |DALI | ||
|DNMT1-associated long intergenic non-coding RNA | |DNMT1-associated long intergenic non-coding RNA | ||
+ | |_ | ||
|- | |- | ||
|''DANCR'' | |''DANCR'' | ||
|[[NONHSAT096369]] | |[[NONHSAT096369]] | ||
|differentiation antagonizing non-protein coding RNA | |differentiation antagonizing non-protein coding RNA | ||
− | |ANCR, AGU2, lncRNA-ANCR | + | |"ANCR, AGU2, lncRNA-ANCR" |
+ | |bone diseases | ||
|- | |- | ||
|''DANT1'' | |''DANT1'' | ||
|[[DANT1]] | |[[DANT1]] | ||
|N/A | |N/A | ||
− | |DXZ4 associated non-coding transcript 1, proximal | + | |"DXZ4 associated non-coding transcript 1, proximal" |
+ | |_ | ||
|- | |- | ||
|''DANT2'' | |''DANT2'' | ||
|[[DANT2]] | |[[DANT2]] | ||
|N/A | |N/A | ||
− | |DXZ4 associated non-coding transcript 2, distal | + | |"DXZ4 associated non-coding transcript 2, distal" |
+ | |_ | ||
|- | |- | ||
|''DAOA-AS1'' | |''DAOA-AS1'' | ||
Line 35: | Line 45: | ||
|G30 | |G30 | ||
|DAOA antisense RNA 1 | |DAOA antisense RNA 1 | ||
+ | |bipolar illness,schizophrenia | ||
|- | |- | ||
|''DAPK1-IT1'' | |''DAPK1-IT1'' | ||
Line 40: | Line 51: | ||
|N/A | |N/A | ||
|DAPK1 intronic transcript 1 | |DAPK1 intronic transcript 1 | ||
+ | |pancreatic cancer | ||
|- | |- | ||
|''DBET'' | |''DBET'' | ||
|[[NONHSAT099821]] | |[[NONHSAT099821]] | ||
− | |DBE-T, DUX4L30 | + | |"DBE-T, DUX4L30" |
|D4Z4 binding element transcript (non-protein coding) | |D4Z4 binding element transcript (non-protein coding) | ||
+ | |Pancreatic ductal adenocarcinoma, Facioscapulohumeral muscular dystrophy | ||
|- | |- | ||
|''DBH-AS1'' | |''DBH-AS1'' | ||
Line 50: | Line 63: | ||
|BPR | |BPR | ||
|DBH antisense RNA 1 | |DBH antisense RNA 1 | ||
+ | |hepatocellular carcinoma | ||
|- | |- | ||
|''DGCR10'' | |''DGCR10'' | ||
Line 55: | Line 69: | ||
|DGS-B | |DGS-B | ||
|DiGeorge syndrome critical region gene 10 (non-protein coding) | |DiGeorge syndrome critical region gene 10 (non-protein coding) | ||
+ | |DiGeorge syndrome | ||
|- | |- | ||
|''DGCR11'' | |''DGCR11'' | ||
Line 60: | Line 75: | ||
|DGS-D | |DGS-D | ||
|DiGeorge syndrome critical region gene 11 (non-protein coding) | |DiGeorge syndrome critical region gene 11 (non-protein coding) | ||
+ | |DiGeorge and velo-cardio-facial syndrome | ||
|- | |- | ||
|''DGCR12'' | |''DGCR12'' | ||
Line 65: | Line 81: | ||
|DGS-E | |DGS-E | ||
|DiGeorge syndrome critical region gene 12 (non-protein coding) | |DiGeorge syndrome critical region gene 12 (non-protein coding) | ||
+ | |DiGeorge and velo-cardio-facial syndrome | ||
|- | |- | ||
|''DGCR5'' | |''DGCR5'' | ||
|[[DGCR5]] | |[[DGCR5]] | ||
− | |NCRNA00037, LINC00037 | + | |"NCRNA00037, LINC00037" |
|DiGeorge syndrome critical region gene 5 (non-protein coding) | |DiGeorge syndrome critical region gene 5 (non-protein coding) | ||
+ | |DiGeorge syndrome | ||
|- | |- | ||
|''DGCR9'' | |''DGCR9'' | ||
|[[DGCR9]] | |[[DGCR9]] | ||
− | |DGS-A, POM121L5P | + | |"DGS-A, POM121L5P" |
|DiGeorge syndrome critical region gene 9 (non-protein coding) | |DiGeorge syndrome critical region gene 9 (non-protein coding) | ||
+ | |DiGeorge syndrome | ||
|- | |- | ||
|''DHFR upstream transcripts'' | |''DHFR upstream transcripts'' | ||
|[[NONHSAT102417]] | |[[NONHSAT102417]] | ||
− | |DHFR minor transcript 5'-UTR, ENSG00000228716 | + | |"DHFR minor transcript 5'-UTR, ENSG00000228716" |
|N/A | |N/A | ||
+ | |_ | ||
|- | |- | ||
|''DHRS4-AS1'' | |''DHRS4-AS1'' | ||
|[[NONHSAT035954]] | |[[NONHSAT035954]] | ||
|DHRS4 antisense RNA 1 | |DHRS4 antisense RNA 1 | ||
− | |PRO1488,AS1DHRS4 | + | |"PRO1488,AS1DHRS4" |
+ | |_ | ||
|- | |- | ||
|''DIAPH2-AS1'' | |''DIAPH2-AS1'' | ||
Line 90: | Line 111: | ||
|N/A | |N/A | ||
|DIAPH2 antisense RNA 1 | |DIAPH2 antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''DIO3OS'' | |''DIO3OS'' | ||
|[[NONHSAT040032]],[[NONHSAT040039]] | |[[NONHSAT040032]],[[NONHSAT040039]] | ||
− | |DIO3-AS1, NCRNA00041, non-protein coding RNA 41, ENSG00000258498 | + | |"DIO3-AS1, NCRNA00041, ""non-protein coding RNA 41"", ENSG00000258498" |
|DIO3 opposite strand/antisense RNA (head to head) | |DIO3 opposite strand/antisense RNA (head to head) | ||
+ | |_ | ||
|- | |- | ||
|''DISC1FP1'' | |''DISC1FP1'' | ||
Line 100: | Line 123: | ||
|N/A | |N/A | ||
|DISC1 fusion partner 1 (non-protein coding) | |DISC1 fusion partner 1 (non-protein coding) | ||
+ | |_ | ||
|- | |- | ||
|''DISC2'' | |''DISC2'' | ||
|[[NONHSAT010191]] | |[[NONHSAT010191]] | ||
− | |DISC1-AS1, DISC1OS, NCRNA00015 | + | |"DISC1-AS1, DISC1OS, NCRNA00015" |
|disrupted in schizophrenia 2 (non-protein coding) | |disrupted in schizophrenia 2 (non-protein coding) | ||
+ | |affective disorders, Autism spectrum disorder, bipolar disorder, depression, schizophrenia | ||
|- | |- | ||
|''DLEU1'' | |''DLEU1'' | ||
|[[NONHSAT033797]] | |[[NONHSAT033797]] | ||
|deleted in lymphocytic leukemia 1 (non-protein coding) | |deleted in lymphocytic leukemia 1 (non-protein coding) | ||
− | |LEU1, XTP6, NCRNA00021, LINC00021, BCMS1 | + | |"LEU1, XTP6, NCRNA00021, LINC00021, BCMS1" |
+ | |chronic lymphocytic leukemia | ||
|- | |- | ||
|''DLEU2'' | |''DLEU2'' | ||
|[[NONHSAT033821]] | |[[NONHSAT033821]] | ||
|deleted in lymphocytic leukemia 2 (non-protein coding) | |deleted in lymphocytic leukemia 2 (non-protein coding) | ||
− | |LEU2, TRIM13OS, NCRNA00022, LINC00022, MIR15AHG | + | |"LEU2, TRIM13OS, NCRNA00022, LINC00022, MIR15AHG" |
+ | |chronic lymphocytic leukemia, lymphocytic leukemia, myeloma | ||
|- | |- | ||
|''DLG2-AS1'' | |''DLG2-AS1'' | ||
|[[DLG2-AS1]] | |[[DLG2-AS1]] | ||
− | |PSZA11q14, SZ-1 | + | |"PSZA11q14, SZ-1" |
|DLG2 antisense RNA 1 | |DLG2 antisense RNA 1 | ||
+ | |schizophrenia | ||
|- | |- | ||
|''DLGAP1-AS3'' | |''DLGAP1-AS3'' | ||
Line 125: | Line 153: | ||
|N/A | |N/A | ||
|DLGAP1 antisense RNA 3 | |DLGAP1 antisense RNA 3 | ||
+ | |_ | ||
|- | |- | ||
|''DLX6-AS1'' | |''DLX6-AS1'' | ||
|[[DLX6-AS1]] | |[[DLX6-AS1]] | ||
− | |FLJ34048, Evf-2 | + | |"FLJ34048, Evf-2" |
|DLX6 antisense RNA 1 | |DLX6 antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''DNM3OS'' | |''DNM3OS'' | ||
|[[DNM3OS]] | |[[DNM3OS]] | ||
− | |MIR199A2HG, DNM3-AS1 | + | |"MIR199A2HG, DNM3-AS1" |
|DNM3 opposite strand/antisense RNA | |DNM3 opposite strand/antisense RNA | ||
+ | |Sézary syndrome | ||
|- | |- | ||
|''DRAIC'' | |''DRAIC'' | ||
|[[DRAIC]] | |[[DRAIC]] | ||
|N/A | |N/A | ||
− | |downregulated RNA in cancer, inhibitor of cell invasion and migration | + | |"downregulated RNA in cancer, inhibitor of cell invasion and migration" |
+ | |prostate cancer, bladder cancer, low-grade gliomas, lung adenocarcinoma, stomach adenocarcinoma, renal clear cell carcinoma, hepatocellular carcinoma, skin melanoma | ||
|- | |- | ||
|''DSCR10'' | |''DSCR10'' | ||
Line 145: | Line 177: | ||
|N/A | |N/A | ||
|Down syndrome critical region 10 (non-protein coding) | |Down syndrome critical region 10 (non-protein coding) | ||
+ | |_ | ||
|- | |- | ||
|''DSCR9'' | |''DSCR9'' | ||
Line 150: | Line 183: | ||
|NCRNA00038 | |NCRNA00038 | ||
|Down syndrome critical region 9 (non-protein coding) | |Down syndrome critical region 9 (non-protein coding) | ||
+ | |_ | ||
|- | |- | ||
|''DUBR'' | |''DUBR'' | ||
Line 155: | Line 189: | ||
|N/A | |N/A | ||
|DPPA2 upstream binding RNA | |DPPA2 upstream binding RNA | ||
+ | |_ | ||
+ | |- | ||
+ | |''DLGAP4-AS1'' | ||
+ | |[[DLGAP4-AS1]] | ||
+ | |CCAT7 | ||
+ | |DLGAP4 antisense RNA 1 | ||
+ | |colorectal cancer | ||
+ | |- | ||
+ | |''DM1-AS'' | ||
+ | |[[DM1-AS]] | ||
+ | |N/A | ||
+ | |DM1 locus antisense RNA | ||
+ | |Myotonic dystrophy type 1 | ||
+ | |- | ||
+ | |''DPYD-AS2'' | ||
+ | |[[DPYD-AS2]] | ||
+ | |N/A | ||
+ | |DPYD antisense RNA 2 | ||
+ | |Cervical squamous cancers | ||
+ | |- | ||
+ | |''DSCAM-AS1'' | ||
+ | |[[DSCAM-AS1]] | ||
+ | |M41 | ||
+ | |DSCAM antisense RNA 1 | ||
+ | |breast cancer | ||
+ | |- | ||
+ | |''DSCR4'' | ||
+ | |[[DSCR4]] | ||
+ | |DCRB | ||
+ | |Down syndrome critical region 4 | ||
+ | |Down syndrome | ||
+ | |- | ||
+ | |''DSCR8'' | ||
+ | |[[DSCR8]] | ||
+ | |C21orf65, MTAG2, CT25.1a, CT25.1b, MMA-1a, MMA-1b | ||
+ | |Down syndrome critical region 8 (non-protein coding) | ||
+ | |Down syndrome, melanoma | ||
+ | |- | ||
+ | |''DARS-AS1'' | ||
+ | |[[DARS-AS1]] | ||
+ | |N/A | ||
+ | |DARS antisense RNA 1 | ||
+ | |_ | ||
+ | |- | ||
+ | |''DCST1-AS1'' | ||
+ | |[[DCST1-AS1]] | ||
+ | |RP11-307C12 | ||
+ | |11 | ||
+ | |DCST1 antisense RNA 1 | ||
+ | |- | ||
+ | |''DDN-AS1'' | ||
+ | |[[DDN-AS1]] | ||
+ | |CAT1507 | ||
+ | |DDN and PRKAG1 antisense RNA 1 | ||
+ | |_ | ||
+ | |- | ||
+ | |''DDX11-AS1'' | ||
+ | |[[DDX11-AS1]] | ||
+ | |CONCR | ||
+ | |DDX11 antisense RNA 1 | ||
+ | |_ | ||
+ | |- | ||
+ | |''DINOL'' | ||
+ | |[[DINOL]] | ||
+ | |DINO | ||
+ | |damage induced long noncoding RNA | ||
+ | |_ | ||
+ | |- | ||
+ | |''DNAJB8-AS1'' | ||
+ | |[[DNAJB8-AS1]] | ||
+ | |N/A | ||
+ | |DNAJB8 antisense RNA 1 | ||
+ | |_ | ||
|} | |} |
Latest revision as of 12:35, 29 June 2017
Name | Transcript ID | Alias | Description | Disease |
---|---|---|---|---|
DACOR1 | DACOR1 | TCONSN/A00023265 | DNMT1-associated colon cancer repressed lncRNA 1 | colon cancer |
DALIR | DALIR | DALI | DNMT1-associated long intergenic non-coding RNA | _ |
DANCR | NONHSAT096369 | differentiation antagonizing non-protein coding RNA | "ANCR, AGU2, lncRNA-ANCR" | bone diseases |
DANT1 | DANT1 | N/A | "DXZ4 associated non-coding transcript 1, proximal" | _ |
DANT2 | DANT2 | N/A | "DXZ4 associated non-coding transcript 2, distal" | _ |
DAOA-AS1 | DAOA-AS1 | G30 | DAOA antisense RNA 1 | bipolar illness,schizophrenia |
DAPK1-IT1 | DAPK1-IT1 | N/A | DAPK1 intronic transcript 1 | pancreatic cancer |
DBET | NONHSAT099821 | "DBE-T, DUX4L30" | D4Z4 binding element transcript (non-protein coding) | Pancreatic ductal adenocarcinoma, Facioscapulohumeral muscular dystrophy |
DBH-AS1 | DBH-AS1 | BPR | DBH antisense RNA 1 | hepatocellular carcinoma |
DGCR10 | DGCR10 | DGS-B | DiGeorge syndrome critical region gene 10 (non-protein coding) | DiGeorge syndrome |
DGCR11 | DGCR11 | DGS-D | DiGeorge syndrome critical region gene 11 (non-protein coding) | DiGeorge and velo-cardio-facial syndrome |
DGCR12 | DGCR12 | DGS-E | DiGeorge syndrome critical region gene 12 (non-protein coding) | DiGeorge and velo-cardio-facial syndrome |
DGCR5 | DGCR5 | "NCRNA00037, LINC00037" | DiGeorge syndrome critical region gene 5 (non-protein coding) | DiGeorge syndrome |
DGCR9 | DGCR9 | "DGS-A, POM121L5P" | DiGeorge syndrome critical region gene 9 (non-protein coding) | DiGeorge syndrome |
DHFR upstream transcripts | NONHSAT102417 | "DHFR minor transcript 5'-UTR, ENSG00000228716" | N/A | _ |
DHRS4-AS1 | NONHSAT035954 | DHRS4 antisense RNA 1 | "PRO1488,AS1DHRS4" | _ |
DIAPH2-AS1 | DIAPH2-AS1 | N/A | DIAPH2 antisense RNA 1 | _ |
DIO3OS | NONHSAT040032,NONHSAT040039 | "DIO3-AS1, NCRNA00041, ""non-protein coding RNA 41"", ENSG00000258498" | DIO3 opposite strand/antisense RNA (head to head) | _ |
DISC1FP1 | DISC1FP1 | N/A | DISC1 fusion partner 1 (non-protein coding) | _ |
DISC2 | NONHSAT010191 | "DISC1-AS1, DISC1OS, NCRNA00015" | disrupted in schizophrenia 2 (non-protein coding) | affective disorders, Autism spectrum disorder, bipolar disorder, depression, schizophrenia |
DLEU1 | NONHSAT033797 | deleted in lymphocytic leukemia 1 (non-protein coding) | "LEU1, XTP6, NCRNA00021, LINC00021, BCMS1" | chronic lymphocytic leukemia |
DLEU2 | NONHSAT033821 | deleted in lymphocytic leukemia 2 (non-protein coding) | "LEU2, TRIM13OS, NCRNA00022, LINC00022, MIR15AHG" | chronic lymphocytic leukemia, lymphocytic leukemia, myeloma |
DLG2-AS1 | DLG2-AS1 | "PSZA11q14, SZ-1" | DLG2 antisense RNA 1 | schizophrenia |
DLGAP1-AS3 | DLGAP1-AS3 | N/A | DLGAP1 antisense RNA 3 | _ |
DLX6-AS1 | DLX6-AS1 | "FLJ34048, Evf-2" | DLX6 antisense RNA 1 | _ |
DNM3OS | DNM3OS | "MIR199A2HG, DNM3-AS1" | DNM3 opposite strand/antisense RNA | Sézary syndrome |
DRAIC | DRAIC | N/A | "downregulated RNA in cancer, inhibitor of cell invasion and migration" | prostate cancer, bladder cancer, low-grade gliomas, lung adenocarcinoma, stomach adenocarcinoma, renal clear cell carcinoma, hepatocellular carcinoma, skin melanoma |
DSCR10 | DSCR10 | N/A | Down syndrome critical region 10 (non-protein coding) | _ |
DSCR9 | DSCR9 | NCRNA00038 | Down syndrome critical region 9 (non-protein coding) | _ |
DUBR | DUBR | N/A | DPPA2 upstream binding RNA | _ |
DLGAP4-AS1 | DLGAP4-AS1 | CCAT7 | DLGAP4 antisense RNA 1 | colorectal cancer |
DM1-AS | DM1-AS | N/A | DM1 locus antisense RNA | Myotonic dystrophy type 1 |
DPYD-AS2 | DPYD-AS2 | N/A | DPYD antisense RNA 2 | Cervical squamous cancers |
DSCAM-AS1 | DSCAM-AS1 | M41 | DSCAM antisense RNA 1 | breast cancer |
DSCR4 | DSCR4 | DCRB | Down syndrome critical region 4 | Down syndrome |
DSCR8 | DSCR8 | C21orf65, MTAG2, CT25.1a, CT25.1b, MMA-1a, MMA-1b | Down syndrome critical region 8 (non-protein coding) | Down syndrome, melanoma |
DARS-AS1 | DARS-AS1 | N/A | DARS antisense RNA 1 | _ |
DCST1-AS1 | DCST1-AS1 | RP11-307C12 | 11 | DCST1 antisense RNA 1 |
DDN-AS1 | DDN-AS1 | CAT1507 | DDN and PRKAG1 antisense RNA 1 | _ |
DDX11-AS1 | DDX11-AS1 | CONCR | DDX11 antisense RNA 1 | _ |
DINOL | DINOL | DINO | damage induced long noncoding RNA | _ |
DNAJB8-AS1 | DNAJB8-AS1 | N/A | DNAJB8 antisense RNA 1 | _ |